19.735 USD
+0.63 (+3.27%)
Taking everything into account, TNDM scores 2 out of 10 in our fundamental rating. TNDM was compared to 184 industry peers in the Health Care Equipment & Supplies industry. TNDM may be in some trouble as it scores bad on both profitability and health. TNDM is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- TNDM had negative earnings in the past year.
- TNDM had a negative operating cash flow in the past year.
- In the past 5 years TNDM reported 4 times negative net income.
- TNDM had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of TNDM (-23.25%) is comparable to the rest of the industry.
- With a Return On Equity value of -152.95%, TNDM is not doing good in the industry: 67.39% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.25% | ||
| ROE | -152.95% | ||
| ROIC | N/A |
ROA(3y)-14.09%
ROA(5y)-9.07%
ROE(3y)-42.99%
ROE(5y)-26.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TNDM has a Gross Margin (53.23%) which is comparable to the rest of the industry.
- TNDM's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for TNDM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 53.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.92%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- TNDM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for TNDM has been increased compared to 1 year ago.
- The number of shares outstanding for TNDM has been increased compared to 5 years ago.
- The debt/assets ratio for TNDM is higher compared to a year ago.
2.2 Solvency
- TNDM has an Altman-Z score of 0.37. This is a bad value and indicates that TNDM is not financially healthy and even has some risk of bankruptcy.
- TNDM has a Altman-Z score of 0.37. This is comparable to the rest of the industry: TNDM outperforms 46.74% of its industry peers.
- A Debt/Equity ratio of 2.37 is on the high side and indicates that TNDM has dependencies on debt financing.
- With a Debt to Equity ratio value of 2.37, TNDM is not doing good in the industry: 83.15% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.37 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.37 |
ROIC/WACCN/A
WACC9.1%
2.3 Liquidity
- TNDM has a Current Ratio of 2.44. This indicates that TNDM is financially healthy and has no problem in meeting its short term obligations.
- TNDM's Current ratio of 2.44 is in line compared to the rest of the industry. TNDM outperforms 50.54% of its industry peers.
- A Quick Ratio of 1.90 indicates that TNDM should not have too much problems paying its short term obligations.
- TNDM has a Quick ratio of 1.90. This is comparable to the rest of the industry: TNDM outperforms 52.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
- TNDM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.53%, which is quite good.
- The Revenue has grown by 17.87% in the past year. This is quite good.
- TNDM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.01% yearly.
EPS 1Y (TTM)16.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.43%
Revenue 1Y (TTM)17.87%
Revenue growth 3Y10.19%
Revenue growth 5Y21.01%
Sales Q2Q%2.17%
3.2 Future
- TNDM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.39% yearly.
- Based on estimates for the next years, TNDM will show a quite strong growth in Revenue. The Revenue will grow by 9.13% on average per year.
EPS Next Y-29.52%
EPS Next 2Y15.15%
EPS Next 3Y22.25%
EPS Next 5Y20.39%
Revenue Next Year10.11%
Revenue Next 2Y10.15%
Revenue Next 3Y9.9%
Revenue Next 5Y9.13%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for TNDM. In the last year negative earnings were reported.
- Also next year TNDM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as TNDM's earnings are expected to grow with 22.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.15%
EPS Next 3Y22.25%
5. Dividend
5.1 Amount
- TNDM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TANDEM DIABETES CARE INC / TNDM FAQ
What is the ChartMill fundamental rating of TANDEM DIABETES CARE INC (TNDM) stock?
ChartMill assigns a fundamental rating of 2 / 10 to TNDM.
What is the valuation status of TANDEM DIABETES CARE INC (TNDM) stock?
ChartMill assigns a valuation rating of 1 / 10 to TANDEM DIABETES CARE INC (TNDM). This can be considered as Overvalued.
How profitable is TANDEM DIABETES CARE INC (TNDM) stock?
TANDEM DIABETES CARE INC (TNDM) has a profitability rating of 1 / 10.